Skip to main content

HEALTH

  • Schiff Nutrition launches Valentine's Day marketing campaign behind MegaRed

    NEW YORK — Schiff Nutrition Group and M&C Saatchi NY on Tuesday launched a Valentine’s Day marketing campaign — “Whose Heart Do You Love” — in support of MegaRed krill oil supplements. 

  • Titan Medical Enterprises shut down after violating drug, supplement good manufacturing practices

    SILVER SPRING, Md. — A federal judge has ordered a California company and its owner to stop manufacturing and distributing drugs and dietary supplements in domestic commerce until their manufacturing operations comply with the Federal Food, Drug, and Cosmetic Act, the Food and Drug Administration reported Friday. 

  • FDA turns down two Novo Nordisk insulin products

    BAGSVÆRD, Denmark — The Food and Drug Administration declined to approve two insulin products made by Danish drug maker Novo Nordisk, the company said Sunday.

    Novo Nordisk said it received complete response letters from the FDA for Tresiba (insulin degludec) and Ryzodeg (insulin degludec and insulin aspart). The FDA issues a complete response letter when it has finished reviewing an application for a drug, but determines that the application can't be approved in its current form.

  • Former discount retail execs team up on new retail, wholesale business

    ST. LOUIS — A group of former executives from Save-A-Lot, Grandpa's Stores and Deals: Nothing Over a Dollar has teamed up to create a new business venture that they said would combine wholesale, retail and e-commerce components.

  • Flu still 'Texas big' in the Lone Star and neighboring states

    ATLANTA — For the week ended Feb. 2, influenza activity remained elevated in the United States but decreased in most areas, the Centers for Disease Control and Prevention reported Friday. According to CDC's activity level map, it appears most incidence is concentrated across the central United States, including Texas, Oklahoma, Kansas and Missouri. 

  • Report: New FDA switch paradigm could bring $36 billion in prescription revenue to the front end

    MONMOUTH BEACH, N.J. — A new switch paradigm could open the door to $35.7 billion in OTC opportunity, according to a new report recently released by Francesco International. 

  • Type 1 diabetes spikes among Philadelphia children, study finds

    PHILADELPHIA — While much of the attention to diabetes has focused on the dramatic rise of Type 2 diabetes among adults and children alike, a new study by a researcher in Philadelphia has found a spike in Type 1 diabetes among children as well.

  • Rx-to-OTC switches could be boon as FDA looks at switch paradigm

    A new report by Francesco International identified $35.7 billion worth of potential Rx-to-OTC switches in a wide range of indications, from hypertension and chronic obstructive pulmonary disorder to high cholesterol and erectile dysfunction, and the Food and Drug Administration has been looking at ways technology and pharmacists could be employed to ensure that patients taking drugs new to the consumer health space take them appropriately

Related Topics

X
This ad will auto-close in 10 seconds